Variant report
Variant | esv3340146 |
---|---|
Chromosome Location | chr2:206149496-206150853 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201426604 | chr2:206149596-206149597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11677344 | chr2:206149607-206149608 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs13002238 | chr2:206149623-206149624 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs530942406 | chr2:206149680-206149681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs5837964 | chr2:206149717-206149718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199751161 | chr2:206149731-206149732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs397786341 | chr2:206149732-206149733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200553503 | chr2:206149733-206149734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543002897 | chr2:206149804-206149805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532320070 | chr2:206149816-206149817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377516755 | chr2:206149898-206149899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs35637123 | chr2:206149980-206149981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561027487 | chr2:206150021-206150022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73056488 | chr2:206150033-206150034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374041647 | chr2:206150038-206150039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72940370 | chr2:206150056-206150057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138623361 | chr2:206150088-206150089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1540369 | chr2:206150152-206150153 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs550278645 | chr2:206150154-206150155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568573819 | chr2:206150164-206150165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535851355 | chr2:206150267-206150268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554599423 | chr2:206150285-206150286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564884446 | chr2:206150293-206150294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1207422 | chr2:206150373-206150374 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs535360626 | chr2:206150436-206150437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114529064 | chr2:206150466-206150467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115195060 | chr2:206150480-206150481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149325055 | chr2:206150554-206150555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs1207421 | chr2:206150594-206150595 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
30 | rs1207420 | chr2:206150675-206150676 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs368284308 | chr2:206150686-206150687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561369099 | chr2:206150711-206150712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7569859 | chr2:206150747-206150748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182640333 | chr2:206150822-206150823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cancer | 20164920 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:206097200-206170600 | Weak transcription | HSMMtube | muscle |
2 | chr2:206118200-206156600 | Weak transcription | Aorta | Aorta |
3 | chr2:206138800-206162200 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr2:206147400-206149600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr2:206148400-206149600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr2:206148400-206149600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr2:206149000-206156800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr2:206149200-206150800 | Weak transcription | H1 Cell Line | embryonic stem cell |
9 | chr2:206149400-206154200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:206149400-206154600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr2:206149400-206158200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr2:206149400-206160000 | Weak transcription | Psoas Muscle | Psoas |
13 | chr2:206149600-206154600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
14 | chr2:206149600-206158200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |